Trastuzumab-Induced Tumor Microenvironment Changes in Early HER2+Breast Cancer

被引：0
|
作者：
Kennedy, Laura C.
Alvarez, Rebeca
Dintzis, Suzanne
Gadi, Vijayakrishna K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-23-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-23-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+Breast Cancer
    Song, Patrick N.
    Mansur, Ameer
    Lu, Yun
    Della Manna, Deborah
    Burns, Andrew
    Samuel, Sharon
    Heinzman, Katherine
    Lapi, Suzanne E.
    Yang, Eddy S.
    Sorace, Anna G.
    CANCERS, 2022, 14 (04)
  • [2] Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+Breast Cancer
    Syed, Anum K.
    Woodall, Ryan
    Whisenant, Jennifer G.
    Yankeelov, Thomas E.
    Sorace, Anna G.
    NEOPLASIA, 2019, 21 (01): : 17 - 29
  • [3] Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+breast cancer
    Bloom, M. J.
    Jarrett, A. M.
    Triplett, T. A.
    Syed, A. K.
    Yankeelov, T. E.
    Sorace, A. G.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+breast cancer
    Jarrett, Angela M.
    Bloom, Meghan J.
    Godfrey, Wesley
    Syed, Anum K.
    Ekrut, David A.
    Ehrlich, Lauren I.
    Yankeelov, Thomas E.
    Sorace, Anna G.
    MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA, 2019, 36 (03): : 381 - 410
  • [5] Trastuzumab-induced hypoxia changes in a HER2+murine model of breast cancer
    Sorace, A. G.
    Quarles, C. C.
    Yankeelov, T. E.
    CANCER RESEARCH, 2016, 76
  • [6] Soluble TNFa induced mucin 4 is a mediator of trastuzumab resistance and of an immunosuppressive tumor microenvironment in HER2+breast cancer
    Bruni, Sofia
    De Martino, Mara
    Mauro, Florencia
    Maria de la Parra, Lucia Santa
    Elizalde, Patricia
    Schillaci, Roxana
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] TRASTUZUMAB INDUCED CARDIOTOXICITY IN PATIENTS WITH HER2+BREAST CANCER
    Santamaria Elena, Capilla
    Garcia Beatriz, Benitez
    Jose Antonio, Romero Garrido
    Aunon Pilar, Zamora
    Abad Gema, Casado
    del Valle Luis, Gonzalez
    Ambrosio Alicia, Herrero
    ATENCION FARMACEUTICA, 2013, 15 (04): : 261 - 267
  • [8] Trastuzumab-induced normalization in a HER2+murine model of breast cancer
    Sorace, Anna G.
    Whisenant, Jennifer G.
    McIntyre, J. Oliver
    Yankeelov, Thomas E.
    CANCER RESEARCH, 2015, 75
  • [9] Adjuvant trastuzumab and vinorelbine for early-stage HER2+breast cancer
    McLaughlin, Shannon
    Nakajima, Erika
    Bar, Yael
    Hutchinson, Jennifer A. A.
    Shin, Jennifer
    Moy, Beverly
    Isakoff, Steven J. J.
    Bardia, Aditya
    Kuter, Irene
    Spring, Laura M. M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [10] Trastuzumab-Induced Early Corneal Melt in HER2-Positive Breast Cancer: A Case Report and Review
    Barmas-Alamdari, Daniel
    Chaudhary, Hasnain
    Baghdasaryan, Elmira
    Dua, Prachi
    Cheela, Isha
    AMERICAN JOURNAL OF CASE REPORTS, 2024, 25
12345